| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 07/28/2011 | WO2011091107A2 Film bulk acoustic wave resonator-based ethanol and acetone sensors and methods using the same |
| 07/28/2011 | WO2011091106A2 Compositions and methods for gene signature - based chemical screening |
| 07/28/2011 | WO2011091086A1 Novel reagents for directed biomarker signal amplification |
| 07/28/2011 | WO2011091037A2 Rapid pathogen diagnostic device and method |
| 07/28/2011 | WO2011091007A2 Cell counting and sample chamber and methods of fabrication |
| 07/28/2011 | WO2011090793A2 Multiplex microarray of serially deposited biomolecules on a microarray |
| 07/28/2011 | WO2011090765A1 Diagnostic methods and combination therapies involving mc4r |
| 07/28/2011 | WO2011090745A1 Single molecule detection and sequencing using fluorescence lifetime imaging |
| 07/28/2011 | WO2011090710A2 Composite probes and use thereof in super resolution methods |
| 07/28/2011 | WO2011090662A2 Rapid detection of molds that produce glucose oxidase |
| 07/28/2011 | WO2011090557A1 Method for determining copy number variations |
| 07/28/2011 | WO2011090516A1 Antibodies and methods of diagnosing diseases |
| 07/28/2011 | WO2011090441A1 A process for making a microarray |
| 07/28/2011 | WO2011090351A2 Diagnostic method and diagnosing kit for prostatitis |
| 07/28/2011 | WO2011090166A1 Esophageal cancer marker |
| 07/28/2011 | WO2011090159A1 Probe reagent for measurement of protein decomposition activity |
| 07/28/2011 | WO2011090091A1 Method for determination whether or not cell population is suitable for foreign gene transfer for the purpose of preparation of adipocytes for gene therapy application |
| 07/28/2011 | WO2011090017A1 Method for immunoassay of autoantibody against ku86, kit for use in same, and method for determination of primary hepatocellular carcinoma using same |
| 07/28/2011 | WO2011089988A1 Method for detecting pancreatic cancer |
| 07/28/2011 | WO2011089966A1 Sample analysis device |
| 07/28/2011 | WO2011089923A1 Automatic analyzer and analysis method |
| 07/28/2011 | WO2011089903A1 A method for immobilizing protein a on a self-assembled monolayer |
| 07/28/2011 | WO2011089897A1 Method for detection of fluorescence, process for production of fluorescent beads, and fluorescent beads |
| 07/28/2011 | WO2011089659A1 Method for determining fuel property and device for determining fuel property |
| 07/28/2011 | WO2011089636A1 Method for in vitro detection of ataxia telangiectasia healthy carriers and related kit |
| 07/28/2011 | WO2011089532A1 Detection apparatus and detection method |
| 07/28/2011 | WO2011089453A2 Mass spectrometry-based protein identification |
| 07/28/2011 | WO2011089392A1 Methods & devices for diagnosing cardiac disorders |
| 07/28/2011 | WO2011089357A1 Method, device and removable part for measuring aggregation speed |
| 07/28/2011 | WO2011089299A1 Methods and compositions for identifying embryotoxic compounds |
| 07/28/2011 | WO2011089267A1 Silylated biomolecules |
| 07/28/2011 | WO2011089257A1 Method for determining the activity of transglutaminase factor xiiia |
| 07/28/2011 | WO2011089240A1 Diagnostic method for endometrial receptivity |
| 07/28/2011 | WO2011089202A1 Method for evaluating the solubility of a crystalline substance in a polymer |
| 07/28/2011 | WO2011089194A1 Methods and uses relating to the identification of compound involved in pain as well as methods of diagnosing algesia |
| 07/28/2011 | WO2011089192A1 Methods and uses relating to the identification of compound involved in pain as well as methods of diagnosing algesia |
| 07/28/2011 | WO2011089146A1 Method for assaying diseases characterised by dyslipidemia |
| 07/28/2011 | WO2011089142A1 Flat pop-up test strip container and methods of manufacturing and utilization thereof |
| 07/28/2011 | WO2011089101A1 Tumor tissue based biomarkers for bevacizumab combination therapies |
| 07/28/2011 | WO2011089004A1 Cancer stem cell markers and uses thereof |
| 07/28/2011 | WO2011088920A1 Indicator device |
| 07/28/2011 | WO2011088825A1 Method and device for determining the sex of fertilized, nonincubated bird eggs |
| 07/28/2011 | WO2011088744A1 Photoluminescent nanoparticle, preparation, and application thereof |
| 07/28/2011 | WO2011088740A1 Enzyme linked immunosorbent assay (elisa) method and kit for detecting soluble programmed cell death protein 5 (pdcd5) |
| 07/28/2011 | WO2011088582A1 Self-metering system and testing device with casing and sliding member to cut-off and set sample volume |
| 07/28/2011 | WO2011088571A1 Device, system and method for quantifying fluorescence and optical properties |
| 07/28/2011 | WO2011088524A1 Methods for regulating blood glucose levels |
| 07/28/2011 | WO2011072177A3 Biomarker assay for diagnosis and classification of cardiovascular disease |
| 07/28/2011 | WO2011063376A3 Mex3c regulation and target to control obesity and diabetes |
| 07/28/2011 | WO2011062803A3 Multiplex immunoassays for hemoglobin, hemoglobin variants, and glycated forms |
| 07/28/2011 | WO2011056655A3 Use of cell lines to determine levels of efficacy of pharmaceutical formulations |
| 07/28/2011 | WO2011047337A3 Cell-based complement activation product algorithm for diagnosing systemic lupus erythematosus |
| 07/28/2011 | WO2011036450A3 Splice variants |
| 07/28/2011 | WO2011035012A3 Methods and compositions for diagnosing heart failure |
| 07/28/2011 | WO2011034978A3 Liquid to liquid biological particle concentrator with disposable fluid path |
| 07/28/2011 | WO2011028887A3 Methods and compositions for direct chemical lysis |
| 07/28/2011 | WO2011022590A3 Heavy metal remediation system |
| 07/28/2011 | WO2011022121A9 Analyte sensor fabrication |
| 07/28/2011 | WO2010031506A3 Electrode device, generator device and method for power generation by means of membrane-potential shunting |
| 07/28/2011 | WO2006075185A8 Process for preparation of coated polymer particles containing superparamagnetic crystals |
| 07/28/2011 | US20110185448 Markers associated with soybean rust resistance and methods of use therefor |
| 07/28/2011 | US20110185439 G protein coupled receptors and uses thereof |
| 07/28/2011 | US20110184660 Analyzer of phosphorylation of peptide or protein, phosphorylation determination program, and recording medium for the program |
| 07/28/2011 | US20110184655 Number coding for identification of subtypes of coded types of solid phase carriers |
| 07/28/2011 | US20110184653 Analyte testing method and system |
| 07/28/2011 | US20110184651 Electronic assay apparatus and method thereof |
| 07/28/2011 | US20110184268 Method, Device and System for Providing Analyte Sensor Calibration |
| 07/28/2011 | US20110184264 Universal Test Strip Port |
| 07/28/2011 | US20110184259 Fiber Optic Device for Sensing Analytes and Method of Making Same |
| 07/28/2011 | US20110184254 Detection of intraamniotic infection |
| 07/28/2011 | US20110184204 Catalytic systems for the conversion of hydrocarbons to functionalized products |
| 07/28/2011 | US20110184153 Modified gherlin peptides |
| 07/28/2011 | US20110184145 Method of administering therapeutic polypeptides, and polypeptides therefor |
| 07/28/2011 | US20110184073 Assay |
| 07/28/2011 | US20110184052 Arginase ii: a target for the prevention and treatment of atherosclerosis |
| 07/28/2011 | US20110184051 Pharmacological applications of mitochondrial dna assays |
| 07/28/2011 | US20110183910 Biglycan and related therapeutics and methods of use |
| 07/28/2011 | US20110183904 Methods and compositions for altering behavior associated with autism spectrum disorder |
| 07/28/2011 | US20110183860 Protein Aggregation Domains and Methods of Use Thereof |
| 07/28/2011 | US20110183858 Grading of breast cancer |
| 07/28/2011 | US20110183439 Structures incorporating conformationally flexible conjugated polymers and methods of use |
| 07/28/2011 | US20110183438 Method for Sensing a Substance to be Detected in a Sample |
| 07/28/2011 | US20110183437 Methods of identifying combinations of antibodies with an improved anti-tumor activity and compositions and methods using the antibodies |
| 07/28/2011 | US20110183436 Diagnostic methods for congestive heart failure |
| 07/28/2011 | US20110183434 Diagnostic methods and kits using fibroblast growth factor-23 |
| 07/28/2011 | US20110183432 Test element for analyzing an analyte present in a sample of a body fluid, analysis system and method for controlling the movement of a fluid contained in a channel of a test element |
| 07/28/2011 | US20110183429 Quantitative analysis of vitamin d3, vitamin d2, and metabolites thereof |
| 07/28/2011 | US20110183428 Method for analyzing c-terminal amino acid sequence of peptide using mass spectrometry |
| 07/28/2011 | US20110183427 Method for separating the constituents of a complex mixture of proteins to submit to proteomic analysis and apparatus therefor |
| 07/28/2011 | US20110183426 Methods for Chemical Equivalence in Characterizing of Complex Molecules |
| 07/28/2011 | US20110183425 Protein Complexes and Screening Methods |
| 07/28/2011 | US20110183424 Screening for neurotoxic amino acid associated with neurological disorders |
| 07/28/2011 | US20110183422 Measurement of curing |
| 07/28/2011 | US20110183420 Mass tag reagents for simultaneous quantitation and identification of small molecules |
| 07/28/2011 | US20110183416 Method of modulating the proliferation of medullary thyroid carcinoma cells |
| 07/28/2011 | US20110183367 Device and method for non-invasive measurement of the individual metabolic rate of a substantially spherical metabolizing particle |
| 07/28/2011 | US20110183364 Analytical method for the detection of latent hepatitis c, use thereof and corresponding diagnosis kit |
| 07/28/2011 | US20110183363 Assays for detecting antibodies specific to therapeutic anti-ige antibodies and their use in anaphylaxis |
| 07/28/2011 | US20110183362 Compositions and methods for measuring levels of bioactive human hepcidin |
| 07/28/2011 | US20110183360 Antibodies to clostridium difficile spores and uses thereof |